Rhoifolin attenuates atopic dermatitis-like symptoms in mice by regulating PPARα-mediated NF-κB/NLRP3 inflammation and pyroptosis processes
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.110563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Hui Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, Sichuan 610041, PR China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, PPAR alpha, NF-kappa B, Inflammation. Die Arbeit nennt 37 Literaturangaben. Gefördert von: The Affiliated Hospital of Southwest Medical University, Southwest Medical University.
Abstract (Originalsprache)
Rhoifolin (ROF), a naturally occurring flavonoid glycoside, has been documented to possess a broad spectrum of biological properties, including anticancer, antioxidant, neuroprotective, hepatoprotective, anti-inflammatory, and antiviral activities. Atopic dermatitis (AD) is a persistent, recurring inflammatory skin illness that frequently greatly compromises the patients' quality of life. Nevertheless, the role of ROF in AD pathogenesis and the associated molecular events have yet to be elucidated. Our findings revealed that ROF administration substantially ameliorated the 1-chloro-2,4-dinitrobenzene (DNCB)-induced AD-like phenotypes, as reflected by decreased mast cell accumulation, reduced CD4+ and CD8+ T cells infiltration within lesional skin, lowered serum immunoglobulin E (IgE) concentrations, attenuated epidermal and dermal thickening, suppressed histamine liberation and pruritic episodes, improved SCORAD indices, concomitant restoration of skin barrier protein expression, and curtailed the production of multiple inflammatory factors. Mechanistic investigations, integrating network pharmacology forecasts, transcriptomic profiling, and pharmacological blockade experiments with specific antagonists, further confirmed that the anti-inflammatory action of ROF operates through the PPARα-regulated NF-κB/NLRP3 signaling cascade. Collectively, these observations demonstrate that ROF exerts favorable inhibitory effects against AD-like inflammation both in vivo and in vitro, underscoring its potential as a viable therapeutic option for managing AD and other inflammatory cutaneous disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, Sichuan 610041, PR China.
- Department of Pharmacy, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, PR China.
- Grade 2023, Pharmacy Program, Class 4, Southwest Medical University, Luzhou, Sichuan 646000, PR China.
- Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, PR China. Electronic address: minghualiu_swmu@163.com.
- Department of Infectious Diseases, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, PR China. Electronic address: 18883124396@163.com.
- Department of Pharmacy, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, PR China. Electronic address: zhaoge99@swmu.edu.cn.
Förderung
- The Affiliated Hospital of Southwest Medical University
- Southwest Medical University
Zitieren
APA
Li, H., Luo, H., Zhang, X., Luo, J., Zhan, C., Gong, X., Liu, M., Chen, X., & Zhao, G. (2026). Rhoifolin attenuates atopic dermatitis-like symptoms in mice by regulating PPARα-mediated NF-κB/NLRP3 inflammation and pyroptosis processes. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110563
Vancouver
Li H, Luo H, Zhang X, Luo J, Zhan C, Gong X, et al. Rhoifolin attenuates atopic dermatitis-like symptoms in mice by regulating PPARα-mediated NF-κB/NLRP3 inflammation and pyroptosis processes. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110563
BibTeX
@article{Li2026,
author = {Li, Hui and Luo, Hengli and Zhang, Xin and Luo, Jianchun and Zhan, Chenglin and Gong, Xiaofang and Liu, Minghua and Chen, Xiangfeng and Zhao, Ge},
title = {Rhoifolin attenuates atopic dermatitis-like symptoms in mice by regulating PPARα-mediated NF-κB/NLRP3 inflammation and pyroptosis processes},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.110563}
}
EUVIMED